Literature DB >> 30145547

Clinical and microbiological profile of infections during induction phase of acute myeloid leukemia.

Sonia Parikh1, Parijat Goswami2, Asha Anand1, Harsha Panchal1, Apurva Patel1, Rahul Kulkarni1, Bhadresh Shastri1.   

Abstract

BACKGROUND: The primary objective of this study is to describe clinical and microbiological profile of infections during induction phase of acute myeloid leukemia (AML). PATIENTS AND METHODS: We reviewed the case records of 50 hospitalized patients with AML undergoing standard dose induction chemotherapy from January to December 2015.
RESULTS: Out of 50 cases, 34 were males 16 females with median age of 30 years. Most common presenting symptoms were fever followed by bleeding diathesis. The clinical sites of infections were gastrointestinal tract including oral cavity (48%), respiratory tract (4%), skin/soft tissue (4%) and genitourinary tract (4%). Clinically (58%) or microbiologically (30%) documented infections were 88%, while 12% had fever without identifiable source. Overall, in 21 episodes microorganisms were isolated. Common sites of isolates were blood stream (11), stool (8), sputum (1) and urine (1). Gram negative infections accounted for 81% of total isolates; Escherichia coli (E. coli) being the commonest. Gram positive microorganisms were isolated in 19% of which methicillin resistant staphylococcus aureus (MRSA) was the most common. Gram negative bacterial infections were associated with higher mortality.
CONCLUSION: Gastrointestinal tract is the most common clinical site of infection. Blood stream infection is the most common site for positive bacterial isolates. Gramnegative bacilli were the predominant cause of infections with E. coli being the most common pathogen isolated. Empiric antibiotic treatment for febrile neutropenia should be tailored to the locally prevalent pathogens and their susceptibility patterns.

Entities:  

Keywords:  AML; Escherichia coli E. Coli.; blood stream infection; induction chemotherapy

Mesh:

Substances:

Year:  2018        PMID: 30145547

Source DB:  PubMed          Journal:  Gulf J Oncolog        ISSN: 2078-2101


  3 in total

1.  F Plasmid Lineages in Escherichia coli ST95: Implications for Host Range, Antibiotic Resistance, and Zoonoses.

Authors:  Max Laurence Cummins; Cameron J Reid; Steven Philip Djordjevic
Journal:  mSystems       Date:  2022-01-25       Impact factor: 6.496

2.  The clinical profile, management, and outcome of febrile neutropenia in acute myeloid leukemia from resource constraint settings.

Authors:  Kundan Mishra; Suman Kumar; Sandeep Ninawe; Rajat Bahl; Ashok Meshram; Kanwaljeet Singh; Aditya Jandial; Kamal Kant Sahu; Rajeev Sandal; Sanjeev Khera; Uday Yanamandra; Harshit Khurana; Rajiv Kumar; Rajan Kapoor; Sanjeevan Sharma; Jasjit Singh; Satyaranjan Das; Ankur Ahuja; Venkateshan Somasundaram; Tathagat Chaterjee
Journal:  Ther Adv Infect Dis       Date:  2021-08-04

3.  Induction therapy for acute lymphoblastic leukemia: incidence and risk factors for bloodstream infections.

Authors:  Rosângela Aparecida Mendes Silva; Regina Maria Holanda de Mendonça; Simone Dos Santos Aguiar; Júlia Cervellini Yajima; Fernando Augusto Lima Marson; Silvia Regina Brandalise; Carlos Emílio Levy
Journal:  Support Care Cancer       Date:  2021-08-07       Impact factor: 3.603

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.